Intravenous methylprednisolone for multiple sclerosis in relapse.
作者信息
Barnes M P, Bateman D E, Cleland P G, Dick D J, Walls T J, Newman P K, Saunders M, Tilley P J
出版信息
J Neurol Neurosurg Psychiatry. 1985 Feb;48(2):157-9. doi: 10.1136/jnnp.48.2.157.
Abstract
A randomised comparison is made between methylprednisolone, 1 g intravenously daily for 7 days, and a standard ACTH regime for the treatment of multiple sclerosis in acute relapse. It is found that methylprednisolone produces a more rapid clinical improvement than ACTH but confers no longer term benefit when the two treatments are compared at 3 months. It is proposed that intravenous methylprednisolone does have a role to play in the management of a patient with an acute relapse of multiple sclerosis.
摘要
相似文献
1
Intravenous methylprednisolone for multiple sclerosis in relapse.
J Neurol Neurosurg Psychiatry. 1985 Feb;48(2):157-9. doi: 10.1136/jnnp.48.2.157.
2
Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS.
Neurology. 1989 Jul;39(7):969-71. doi: 10.1212/wnl.39.7.969.
3
Use of corticosteroids in multiple sclerosis by consultant neurologists in the United Kingdom.
J Neurol Neurosurg Psychiatry. 1998 Sep;65(3):362-5. doi: 10.1136/jnnp.65.3.362.
4
Corticosteroids and multiple sclerosis.
J Neurol Neurosurg Psychiatry. 1998 Sep;65(3):290. doi: 10.1136/jnnp.65.3.290.
5
"Bolus" methylprednisolone versus ACTH in the treatment of multiple sclerosis.
Ital J Neurol Sci. 1983 Jun;4(2):169-72. doi: 10.1007/BF02043900.
6
[Steroid therapy for multiple sclerosis].
Nihon Rinsho. 2003 Aug;61(8):1361-6.
7
Double-blind randomized trial of ACTH versus dexamethasone versus methylprednisolone in multiple sclerosis bouts. Clinical, cerebrospinal fluid and neurophysiological results.
Eur Neurol. 1989;29(1):10-4. doi: 10.1159/000116368.
8
A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects.
J Neurol Neurosurg Psychiatry. 1987 May;50(5):511-6. doi: 10.1136/jnnp.50.5.511.
9
[Critic study of multiple sclerosis treatment by chlorambucil and intraspinal corticotherapy. Apropos of 100 cases followed up from 2 to 9 years].
Rev Neurol (Paris). 1973 Jan;128(1):72-7.
10
Oral versus intravenous methylprednisolone for the treatment of multiple sclerosis relapses: A meta-analysis of randomized controlled trials.
PLoS One. 2017 Nov 27;12(11):e0188644. doi: 10.1371/journal.pone.0188644. eCollection 2017.
引用本文的文献
1
Anti-IL-6 therapies in central nervous system inflammatory demyelinating diseases.
Front Immunol. 2022 Oct 27;13:966766. doi: 10.3389/fimmu.2022.966766. eCollection 2022.
2
A Prospective Observational Registry of Repository Corticotropin Injection (Acthar® Gel) for the Treatment of Multiple Sclerosis Relapse.
Front Neurol. 2020 Dec 22;11:598496. doi: 10.3389/fneur.2020.598496. eCollection 2020.
3
Treatment Effectiveness for Resolution of Multiple Sclerosis Relapse in a US Health Plan Population.
Neurol Ther. 2019 Dec;8(2):383-395. doi: 10.1007/s40120-019-00156-5. Epub 2019 Sep 28.
4
Clinical experience with repository corticotropin injection in patients with multiple sclerosis experiencing mood changes with intravenous methylprednisolone: a case series.
Ther Adv Neurol Disord. 2016 May;9(3):189-97. doi: 10.1177/1756285615618642. Epub 2015 Dec 7.
5
Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases.
PLoS One. 2015 Jul 6;10(7):e0130442. doi: 10.1371/journal.pone.0130442. eCollection 2015.
6
Assessing relapses and response to relapse treatment in patients with multiple sclerosis: a nursing perspective.
Int J MS Care. 2012 Fall;14(3):148-59. doi: 10.7224/1537-2073-14.3.148.
7
Treatment of acute relapses in multiple sclerosis.
Neurotherapeutics. 2013 Jan;10(1):97-105. doi: 10.1007/s13311-012-0160-7.
8
A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy.
Neurol Sci. 2013 Feb;34(2):197-203. doi: 10.1007/s10072-012-0981-5. Epub 2012 Mar 11.
9
Multiple sclerosis: diagnosis and the management of acute relapses.
Postgrad Med J. 2005 May;81(955):302-8. doi: 10.1136/pgmj.2004.029413.
10
Current pharmacologic treatment of multiple sclerosis symptoms.
West J Med. 1996 Nov;165(5):313-7.
本文引用的文献
1
FURTHER NOTES ON DISABILITY EVALUATION IN MULTIPLE SCLEROSIS, WITH SCALE MODIFICATIONS.
Neurology. 1965 Jul;15:654-61. doi: 10.1212/wnl.15.7.654.
2
Treatment of acute exacerbations of multiple sclerosis with intravenous methyl-prednisolone.
J Neurol Neurosurg Psychiatry. 1982 Feb;45(2):179-80. doi: 10.1136/jnnp.45.2.179-a.
3
Prolonged effects of large-dose methylprednisolone infusion in multiple sclerosis.
Neurology. 1980 Jul;30(7 Pt 1):702-8. doi: 10.1212/wnl.30.7.702.
4
Possible beneficial effect of high-dose intravenous steroid therapy in acute demyelinating disease and transverse myelitis.
Neurology. 1980 Jul;30(7 Pt 2):33-6. doi: 10.1212/wnl.30.7_part_2.33.
5
Cooperative study in the evaluation of therapy in multiple sclerosis. ACTH vs. placebo--final report.
Neurology. 1970 May;20(5):1-59. doi: 10.1212/wnl.20.5_part_2.1.
6
Long-term treatment of multiple sclerosis with corticotrophin.
Lancet. 1967 Aug 26;2(7513):429-31. doi: 10.1016/s0140-6736(67)90850-1.
Zotero 插件